Monday, September 8, 2008

Fluidigm Sets Offering Terms

South San Francisco-based Fluidigm, a maker of genetic analysis circuits, said in a filing with the SEC Friday that it will offer 5,300,000 shares of its common stock at between $14.00 and $16.00 per share. The firm is listing its IPO on the NASDAQ Global Market as FLDM. The firm's IPo is being underwritten by Morgan Stanley, UBS Investment Bank, Leerink Swann, and Pacific Growth Equities. The firm is venture backed by Alloy Funds, EuclidSR, Fidelty Funds, InterWest, Lehman Brothers, SMALLCAP World Fund, Versant Ventures, and the government of Singapore.